Search Results

You searched for : TreatmentforCovid  

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ...
Jun 28

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ...
Jun 28

AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe

In fewer than twelve months, AstraZeneca has worked extremely hard to develop an effective vaccine at no profit and is the second-largest supplier to ...
Jun 18

DATA PUBLISHED IN NEW ENGLAND JOURNAL OF MEDICINE SHOWS PFIZER’S TOFACITINIB MEETS PRIMARY ENDPOINT IN BRAZILIAN STUDY IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA

It is important to note that tofacitinib has not been approved or authorized for use by any regulatory authority worldwide for the treatment of COVID-...
Jun 17

COVID-19 Vaccine AstraZeneca effective against Delta (‘Indian’) variant

Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant ...
Jun 16

CSIR-IICT and SUVEN Pharmaceuticals Ltd., joined hands for the process technology transfer and manufacture of anti COVID drugs Molnupiravir and 2-DG

Molnupiravir, the antiviral drug was initially developed for the treatment of influenza and is repurposed to completely suppress the COVID virus transmission within 24 hours....
Jun 11

PFIZER AND BIONTECH TO PROVIDE 500 MILLION COVID-19 VACCINE TO U.S. GOVERNMENT FOR DONATION TO POOREST NATIONS

These doses are part of Pfizer and BioNTech’s previously announced pledge to provide two billion doses of the COVID-19 vaccine to low- and ...
Jun 10

Rheumatoid arthritis drug reduces risk of death for severely ill hospitalized Covid-19 patients, researchers say

The treatment reduces mortality, shortens hospital stay and reduces the chances of people needing invasive mechanical ventilators...
Feb 12

Pfizer and Biontech publish results of study showing COVID-19 vaccine elicits antibodies that neutralize Pseudovirus bearing the SARS-COV-2 U.K

While the pseudovirus system used is a surrogate for authentic SARS-CoV-2, previous studies have shown excellent concordance between pseudotype neutralization and SARS-CoV-...
Jan 21

Jubilant Therapeutics Announces Research Collaboration with The Wistar Institute to Evaluate the Activity of Novel PAD4 Inhibitors

...
Jan 16

Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19

Vir Biotechnology, Inc. and GlaxoSmithKline plc today announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild ...
Jan 12

Serum Institute of India obtains emergency use authorisation in India for AstraZeneca’s COVID-19 vaccine

AstraZeneca’s COVID-19 vaccine has been granted emergency use authorization in India as well as Argentina, Dominican Republic, El Salvador, Mexico and Morocco for ...
Jan 07

PFIZER AND BIONTECH TO SUPPLY THE U.S. WITH 100 MILLION ADDITIONAL DOSES OF COVID-19 VACCINE

...
Dec 24

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of COVID-19

...
Dec 23

Dr. Reddy's, Global Response Aid, and Appili Therapeutics announce the filing of an application for REEQONUS Tablets

...
Dec 22

Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalized adults with COVID-19

ACTIV-3 is an NIH-led public-private partnership designed to accelerate the development of the most promising treatments and vaccine candidates for COVID-19....
Dec 18

Cipla Launches ‘CIPtest’ Rapid Antigen Detection Test for COVID-19 Diagnosis

CIPtest is a reliable high-performing kit that has been validated and approved by ICMR....
Dec 16

AZD1222 Oxford Phase III trials interim analysis results published in The Lancet

Interim analysis showed vaccine is effective at preventing COVID-19, with no severe cases and no hospitalizations more than 21 days after first injection...
Dec 09

Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application

Rhizen today announced the approval of IND application by the U.S. FDA to study its oral DHODH inhibitor for SARS-CoV-2 infection....
Dec 04

Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India

This will be a multicenter and randomized controlled study, which will include a safety and immunogenicity study....
Dec 02

Hon'ble Prime Minister of India, Shri Narendra Modiji's inspiring presence at the Zydus Biotech Park

Hon'ble Prime Minister's leadership vision, in-depth understanding and knowledge of the facts guided us in facilitating the interactions and discussions on the ...
Nov 30

Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure

The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ...
Nov 23

Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19

Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease...
Nov 23

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in ...
Nov 23

Update on CALAVI Phase II trials for Calquence in patients hospitalised with respiratory symptoms of COVID-19

CALAVI did not meet the primary endpoint of increasing the proportion of patients who remained alive and free of respiratory failure...
Nov 12

25 Matching result(s) found!

-Advertisements-




Trending Now

India Joins International Medical Device Regulators Forum: A Leap Toward Global Health CollaborationOctober 05, 2024
The Science of Overeating: Why You Can’t Stop at Just One BiteOctober 05, 2024
The Toxic Truth: How Alcohol Fuels Six Deadly CancersOctober 05, 2024
Lenacapavir: India’s Pharmaceutical Giants to Produce a Twice-a-Year Pill Poised to Rewrite HIV PreventionOctober 04, 2024
Can Ending Smoking by 2050 Really Save 1.2 Million Lives? New Lancet Study RevealsOctober 04, 2024
Colon Cancer Crisis: Why It’s Attacking Younger GenerationsOctober 04, 2024
Eye Health Program for Low-Income Residents Launched in Hingoli, MaharashtraOctober 04, 2024
Are we on the path to end AIDS by 2030?October 03, 2024
TTK Prestige Announces Shubhutsav- A Special Festive Offer, Elevating Home CookingOctober 03, 2024
Tata Soulfull Launches Tata Soulfull Corn Flakes+, With the Goodness of Millets in Every Flake October 03, 2024
The Bitter Truth Behind Sweet Treats: Hidden Cancer Risks in Your Favorite CakesOctober 03, 2024
Ageing Faster Than You Think? Discover How a Simple Cheek Swab Could Save Your LifeOctober 03, 2024
The University of Tasmania invites international student applications for their Tasmanian International ScholarshipOctober 03, 2024
A New Hope for Type 1 Diabetes: Tackling Blood Sugar Drops with Somatostatin BlockersOctober 03, 2024
Prostate Cancer Strikes Young: The Alarming Rise of Aggressive Cases in Men Under 50October 03, 2024
Fleetguard Filters Private Limited (FFPL) Wins Prestigious ‘Iconic Brands of India 2024’ at the This recognition adds to Fleetguard's growing list of accolades, further establishing its position as a leader in the automotive industry. The company remains dedicated to advancing innovation and providing solutions that consistently meet the changing needs of its customers.October 03, 2024
Marico’s Saffola Honey and Pankaj Tripathi Uncover the Secret of Shuddha Honey in its latest TVCOctober 01, 2024
Mr. Piush Srivastava, Head of Marketing and Corporate Communications of Fleetguard Filters Pvt. Ltd, Awarded 'Marketing Maverick' by Dun & Bradstreet October 01, 2024
Chikungunya Strikes Back: The Forgotten Virus Making a Deadly ComebackOctober 01, 2024
The Hidden Cancer Risk in Your Morning Routine: How Poor Oral Hygiene May Be Endangering Your HealthOctober 01, 2024